GATC Health to Present at Special Addiction Treatment Event at Georgetown University, Washington DC

IRVINE, Calif., May 16, 2022 / GATC Health, a biotech company revolutionizing drug discovery and disease prediction using artificial intelligence and advanced multiomics, today announced that Tyrone Lam, COO of GATC Health, will discuss the future of addiction treatment science during a special one-day event on May 17 in Washington, DC,  Breaking the Stigma and Ending the Addiction Cycle: Critical Steps for States, Counties & Tribes. Held at Georgetown University and streamed virtually, Breaking the Stigma will bring together a broad community of leading experts and influential stakeholders in addiction treatment to discuss new resources, innovative research, effective strategies, and best practices that can be put into practice on the ground.

With U.S. overdose deaths reaching historic highs in 2021, ongoing trials and high-profile settlements with drug companies, and more research available than ever about the opioid epidemic, where do we go from here? Insights shared at the event have been gathered by an independent panel of national experts and addiction professionals over the last 14 months through the invaluable work of the National Substance Use Disorder (SUD) Strategic Advisory Panel (NSUDSAP) and associated workgroups.

The event will include sessions and speakers discussing seven core areas of addiction: treatment, prevention, recovery, the workplace, criminal justice, civil legal aid, and harm reduction.

The event is free; registration is required: https://lightstreamconsulting.org/events/

Among 45 speakers and presenters are, Regina LaBelle, Director, Addiction & Public Policy Initiative, O’Neill Institute for National & Global Health Law at Georgetown University Law Center; Admiral James A. Winnefeld, Former Vice Chairman of the Joint Chiefs of Staff; Dr. Debra Furr-Holden, Dean Designate of the NYU School of Global Public Health; Dr. Stephen Loyd, Chief Medical Officer at Cedar Recovery in Mount Juliet, TN; Tyrone Lam, GATC Health; Dr. Sarah J. Surber, an Assistant Professor at Wayne State University and Environmental Attorney with Thompson Barney; and Sarah Lieber from Stifel Financial Corp.

About GATC HealthGATC Health Corp is a pioneering technology company using whole genome analysis and multiomics-based artificial intelligence to revolutionize disease detection and drug discovery. The company’s patented AI platform reduces risk, time and costs for life science companies by digitally reproducing the human body to find non-obvious answers to biology’s most complex questions. GATC Health is accelerating healthcare’s transition to predictive, individualized medicine.

Disclaimer

The information set forth herein is presented for informational purposes only and should not be deemed an offer to sell securities.  This announcement contains information which the Company believes to be correct, including certain financial information and projections, but the Company does not guarantee as to the accuracy or completeness of such information.  The Company reserves the right to modify or amend the information contained herein.